Ever Neuro Pharma

Ever Neuro Pharma

Unterach, Austria· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $40M

Overview

Ever Neuro Pharma is a long-established, privately-held Austrian company operating in the generic pharmaceuticals sector, with a specific focus on specialty generics and sterile injectable formulations. It leverages end-to-end expertise in development and manufacturing to supply critical-care products worldwide. The company appears to be in a commercial, revenue-generating stage, serving global markets from its base in Unterach near Salzburg.

Generic Drugs

Technology Platform

End-to-end expertise in development and manufacturing of sterile injectable pharmaceutical formulations.

Funding History

2
Total raised:$40M
Series B$25M
Series A$15M

Opportunities

Growing global demand for cost-effective generic injectables, especially in critical care.
Expansion into complex generics and biosimilars presents a significant growth avenue.
Established distribution networks in Europe and the Middle East provide a platform for further geographic market penetration.

Risk Factors

Intense pricing pressure and competition in the generics market.
High regulatory burden and risk of compliance issues in sterile manufacturing.
Vulnerability to supply chain disruptions for raw materials and global logistics.

Competitive Landscape

Operates in the highly competitive global generic pharmaceuticals market, competing with large multinational generics companies (e.g., Teva, Sandoz) as well as specialized injectable manufacturers. Its focus on specialty sterile injectables positions it in a somewhat defensible niche with higher technical barriers to entry.